CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 6th, 2007 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made effective as of the 25th day of September, 2007 (the “Effective Date”) by and between:
